Concentration-dependent effects of anticonvulsant enaminone methyl 4-(4'-bromophenyl)aminocyclohex-3-en-6-methyl-2-oxo-1-oate on neuronal excitability in vitro

Neuroscience

Volumn 141, Issue 1, 2006, Pages 345-356

  Ananthalakshmi, K V V ^a   Edafiogho, I O ^a   Kombian, S B ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Action potentials; Antiepileptic drugs; Ouabain; Seizures; Sodium currents

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CYCLOHEXANE DERIVATIVE; E139 COMPOUND; ENZYME INHIBITOR; OUABAIN; PHOSPHINIC ACID DERIVATIVE; PICROTOXIN; PROPANOLAMINE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

ACTION POTENTIAL; ANIMAL; ARTICLE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; IN VITRO STUDY; MALE; METHODOLOGY; NERVE CELL; NUCLEUS ACCUMBENS; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; RAT;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; HIPPOCAMPUS; MALE; NEURONS; NUCLEUS ACCUMBENS; OUABAIN; PATCH-CLAMP TECHNIQUES; PHOSPHINIC ACIDS; PICROTOXIN; PROPANOLAMINES; RATS; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN;

EID: 33749042155     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.03.021     Document Type: Article

References (40)

1. Agrawal N, Alonso A, Ragsdale DS (2003) Increased persistent sodium currents in rat entorhinal cortex layer V neurons in a poststatus epilepticus model of temporal lobe epilepsy. Epilepsia 44: 1601-1604.
2. Blaustein MP, Robinson SW, Gottlieb SS, Balke CW, Hamlyn JM (2003) Sex, digitalis, and the sodium pump. Mol Interv 3:68-72.
3. Brodie MJ (2001) Do we need any more new antiepileptic drugs? Epilepsy Res 45:3-6.
4. Browne TR, Holmes GL (2001) Epilepsy. N Engl J Med 344:1145-1151.
5. Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25.
6. Catterall WA (2002) Molecular mechanisms of gating and drug block of sodium channels. Novartis Found Symp 241:206-218.
7. Clausen T (2003) Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83:1269-1324.
8. Czapinski P, Blaszczyk B, Czuczwar SJ (2005) Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5:3-14.
9. Dingledine R, McBain CJ, McNamara JO (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 11:334-338.
10. Edafiogho IO, Hinko CN, Moore JA, Mulzac D, Nicholson JM, Scott KR (1992) Synthesis and anticonvulsant activity of enaminones. J Med Chem 35:2798-2805.
11. Edafiogho IO, Denny BJ, Schwable CH, Lowe PR (2003) X-ray cystallographic and theoretical studies of an anticonvulsant enaminone. Med Princ Pract 12:237-242.
12. Errington AC, Stohr T, Lees G (2005) Voltage gated ion channels: targets for anticonvulsant drugs. Curr Top Med Chem 5:15-30.
13. Gadsby DC, Kimura J, Noma A (1985) Voltage dependence of Na/K pump current in isolated heart cells. Nature 315:63-65.
14. Gebhardt C, Breustedt JM, Noldner M, Chatterjee SS, Heinemann U (2001) The antiepileptic drug losigamone decreases the persistent Na+ current in rat hippocampal neurons. Brain Res 920:27-31.
15. Horisberger JD (2004) Recent insights into the structure and mechanism of the sodium pump. Physiology (Bethesda) 19:377-387.
16. Khurana M, Salama NN, Scott KR, Nemieboka NNBKS, Eddington ND (2003) Preclinical evaluation of the pharmacokinetics, brain uptake and metabolism of E121, an anticonvulsant enaminone ester in rats. Biopharm Drug Dispos 24:397-407.
17. Kombian SB, Edafiogho IO, Ananthalakshmi KVV (2005) Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels. Br J Pharmacol 145:945-953.
18. Kuo CC, Bean BP (1994) Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol Pharmacol 46:716-725.
19. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319.
20. Kwan P, Sills GJ, Brodie MJ (2001) The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21-34.
21. Lichtstein D, Rosen H (2001) Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function. Neurochem Res 26:971-978.
22. Lingamaneni R, Hemmings HC Jr (2003) Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABA(A) receptors. Br J Anaesth 90:199-211.
23. Loscher W (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23:113-118.
24. MacDonald RL, Kelly KM (1993) Antiepileptic drug mechanisms of action. Epilepsia 34(Suppl 5):S1-S8.
25. Madeja M, Wolf C, Speckmann EJ (2001) Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame. Brain Res 900:88-94.
26. McNamara JO (1999) Emerging insights into the genesis of epilepsy. Nature 399:A15-A22.
27. Mulzac D, Scott KR (1993) Profile of anticonvulsant activity and minimal toxicity of methy 4[(p-chlorophenyl) amino]-6-methyl-2-oxocyclohex-3-en-1-oate and some prototype antiepileptic drugs in mice and rats. Epilepsia 36(4):1141-1146.
28. Patsalos PN, Lascelles PT (1981) Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. J Neurochem 36:688-695.
29. Phillis JW, Song D, O'Regan MH (1999) Effects of hyperosmolarity and ion substitutions on amino acid efflux from the ischemic rat cerebral cortex. Brain Res 828:1-11.
30. Phillis JW, Wu PU (1981) Catecholamines and the sodium pump in excitable cells. Prog Neurobiol 17:141-184.
31. Reckziegel G, Beck H, Schramm J, Urban BW, Elger CE (1999) Carbamazepine effects on Na+ currents in human dentate granule cells from epileptogenic tissue. Epilepsia 40:401-407.
32. Regesta G, Tanganelli P (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 34:109-122.
33. Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10: 685-692.
34. Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223-286.
35. Scott KR, Rankin GO, Stables JP, Alexander MS, Edafiogho IO, Farrar VA, Kolen KR, Moore JA, Sim LD, Tonnu AD (1995) Synthesis and anticonvulsant activity of enaminones. 3. Investigations on 4'-, 3=-, and 2=-substituted and polysubstituted anilino compounds. Sodium channel binding studies and toxicity evaluations. J Med Chem 38:4033-4043.
36. Sloviter RS (1994) The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 35:640-654.
37. Takahashi M, Hashimoto M (1996) Lowering extracellular Na+ concentration causes NMDA receptor-mediated neuronal death in cultured rat hippocampal slices. Brain Res 735:1-8.
38. Thompson SM, Prince DA (1986) Activation of electrogenic sodium pump in hippocampal CA1 neurons following glutamate-induced depolarization. J Neurophysiol 56:507-522.
39. Wang ZJ, Snell LD, Tabakoff B, Levinson SR (2002) Inhibition of neuronal Na+ channels by the novel antiepileptic compound DCUKA: identification of the diphenylureido moiety as an inactivation modifier. Exp Neurol 178:129-138.
40. White HS (2003) Mechanism of action of newer anticonvulsants. J Clin Psychiatry 64(Suppl 8):5-8.